Clinical Phenotype and Mutation Spectrum of Alzheimer’s Disease with Causative Genetic Mutation in a Chinese Cohort

Author(s): Chenhui Mao, Jie Li, Liling Dong, Xinying Huang, Dan Lei, Jie Wang, Shanshan Chu, Caiyan Liu, Bin Peng, Gustavo C. Román, Liying Cui, Jing Gao*

Journal Name: Current Alzheimer Research

Volume 18 , Issue 3 , 2021


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Alzheimer’s disease with a causative genetic mutation (AD-CGM) is an uncommon form, characterized by a heterogeneous clinical phenotype and variations in the genotype of racial groups affected.

Objective: We aimed to systemically describe the phenotype variance and mutation spectrum in the large sample size of the Peking Union Medical College Hospital (PUMCH) cohort, Beijing, China.

Methods: Next-generation sequencing (NGS) was carried out in 1108 patients diagnosed with dementia. A total of 40 Han Chinese patients with three AD gene mutations were enrolled. A systemic review of all the patients was performed, including clinical history, neurocognitive assessment, brain magnetic resonance imaging, and cerebrospinal fluid (CSF) biomarkers.

Results: We studied the following gene mutation variants: 12 AβPP, 13 PSEN1, and 9 PSEN2, and 23 among them were novel. Most of them were early-onset, but PSEN1 mutation carriers had the youngest onset age. The commonest symptoms were similar to those of AD, including an amnestic syndrome, followed by psychiatric symptoms and movement disorder. On MRI, parietal and posterior temporal atrophy was prominent in PSEN1 and PSEN2 mutation carriers, while AβPP mutation carriers had more vascular changes. The CSF biomarkers profile was indistinguishable from sporadic AD.

Conclusion: We identified a small group of AD-CGM subjects representing 3.6% among more than 1000 demented patients in the PUMCH cohort. These subjects usually presented with early-onset dementia and exhibited significant clinical and genetic heterogeneity. Identification required complete screening of genetic mutations using NGS. Although family history was usually present, we found non-familial cases of all three genetic mutations.

Keywords: Alzheimer's disease, causative genetic mutation, next-generation sequencing, phenotype, amyloid β precursor protein, presenilin gene, variants.

[1]
Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 1995; 375(6534): 754-60.
[http://dx.doi.org/10.1038/375754a0 ] [PMID: 7596406]
[2]
Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 1995; 269(5226): 973-7.
[http://dx.doi.org/10.1126/science.7638622 ] [PMID: 7638622]
[3]
Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 1991; 349(6311): 704-6.
[http://dx.doi.org/10.1038/349704a0 ] [PMID: 1671712]
[4]
Ryan NS, Nicholas JM, Weston PSJ, et al. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: A case series. Lancet Neurol 2016; 15(13): 1326-35.
[http://dx.doi.org/10.1016/S1474-4422(16)30193-4 ] [PMID: 27777022]
[5]
Wu L, Rosa-Neto P, Hsiung GY, et al. Early-onset familial Alzheimer’s disease (EOFAD). Can J Neurol Sci 2012; 39(4): 436-45.
[http://dx.doi.org/10.1017/S0317167100013949 ] [PMID: 22728850]
[6]
Ryan NS, Rossor MN. Correlating familial Alzheimer’s disease gene mutations with clinical phenotype. Biomarkers Med 2010; 4(1): 99-112.
[http://dx.doi.org/10.2217/bmm.09.92 ] [PMID: 20387306]
[7]
Shea YF, Chu LW, Chan AO, Ha J, Li Y, Song YQ. A systematic review of familial Alzheimer’s disease: Differences in presentation of clinical features among three mutated genes and potential ethnic differences. J Formos Med Assoc 2016; 115(2): 67-75.
[http://dx.doi.org/10.1016/j.jfma.2015.08.004 ] [PMID: 26337232]
[8]
Jiang B, Zhou J, Li HL, et al. Mutation screening in Chinese patients with familial Alzheimer’s disease by whole-exome sequencing. Neurobiol Aging 2019; 76: 215.e15-21.
[http://dx.doi.org/10.1016/j.neurobiolaging.2018.11.024 ] [PMID: 30598257]
[9]
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association.. 2013.
[10]
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7(3): 263-9.
[http://dx.doi.org/10.1016/j.jalz.2011.03.005 ] [PMID: 21514250]
[11]
Tan JP, Li N, Gao J, et al. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population. J Alzheimers Dis 2015; 43(4): 1403-12.
[http://dx.doi.org/10.3233/JAD-141278 ] [PMID: 25147113]
[12]
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405-24.
[http://dx.doi.org/10.1038/gim.2015.30 ] [PMID: 25741868]
[13]
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987; 149(2): 351-6.
[http://dx.doi.org/10.2214/ajr.149.2.351 ] [PMID: 3496763]
[14]
Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement 2018; 14(4): 535-62.
[http://dx.doi.org/10.1016/j.jalz.2018.02.018 ] [PMID: 29653606]
[15]
Beck J, Pittman A, Adamson G, et al. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging 2014; 35(1): 261-5.
[http://dx.doi.org/10.1016/j.neurobiolaging.2013.07.017 ] [PMID: 23998997]
[16]
Bagyinszky E, Youn YC, An SS, Kim S. Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries. Clin Interv Aging 2016; 11: 1467-88.
[http://dx.doi.org/10.2147/CIA.S116218 ] [PMID: 27799753]
[17]
Gao Y, Ren RJ, Zhong ZL, et al. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer’s disease. Neurobiol Aging 2019; 77: 154-7.
[http://dx.doi.org/10.1016/j.neurobiolaging.2019.01.018 ] [PMID: 30822634]
[18]
Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease. Alzheimers Dement 2020; 16(1): 178-91.
[http://dx.doi.org/10.1002/alz.12005 ] [PMID: 31914229]
[19]
Ryman DC, Acosta-Baena N, Aisen PS, et al. Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis. Neurology 2014; 83(3): 253-60.
[http://dx.doi.org/10.1212/WNL.0000000000000596 ] [PMID: 24928124]
[20]
Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 2014; 28(1): 19-29.
[http://dx.doi.org/10.1037/neu0000030 ] [PMID: 24219606]
[21]
Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J Neurol 2006; 253(2): 139-58.
[http://dx.doi.org/10.1007/s00415-005-0019-5 ] [PMID: 16267640]
[22]
Larner AJ, Doran M. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer’s disease: An update. J Alzheimers Dis 2009; 17(2): 259-65.
[http://dx.doi.org/10.3233/JAD-2009-1042 ] [PMID: 19221408]
[23]
Larner AJ. Presenilin-1 mutations in Alzheimer’s disease: An update on genotype-phenotype relationships. J Alzheimers Dis 2013; 37(4): 653-9.
[http://dx.doi.org/10.3233/JAD-130746 ] [PMID: 23948899]
[24]
Lopera F, Ardilla A, Martínez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997; 277(10): 793-9.
[http://dx.doi.org/10.1001/jama.1997.03540340027028 ] [PMID: 9052708]
[25]
Mengel D, Liu L, Yamamoto R. A novel V272D presenilin mutation associated with logopenia, disorientation, and apraxia in an autosomal-dominant Alzheimer’s disease family. Neurobiol Aging 2019; 1: e1-3.
[PMID: 31500908]
[26]
Tang MX, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, et al. Neurological manifestations of autosomal dominant Alzheimer’s disease from the DIAN cohort and a meta-analysis. Lancet Neurol 2016; 15: 1317-25.
[http://dx.doi.org/10.1016/S1474-4422(16)30229-0 ] [PMID: 27777020]
[27]
Roks G, Van Harskamp F, De Koning I, et al. Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 2000; 123(Pt 10): 2130-40.
[http://dx.doi.org/10.1093/brain/123.10.2130 ] [PMID: 11004129]
[28]
Scahill RI, Ridgway GR, Bartlett JW, et al. Genetic influences on atrophy patterns in familial Alzheimer’s disease: A comparison of APP and PSEN1 mutations. J Alzheimers Dis 2013; 35(1): 199-212.
[http://dx.doi.org/10.3233/JAD-121255 ] [PMID: 23380992]
[29]
Ryan NS, Biessels GJ, Kim L, et al. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer’s disease. Neurobiol Aging 2015; 36(12): 3140-51.
[http://dx.doi.org/10.1016/j.neurobiolaging.2015.08.026 ] [PMID: 26410308]
[30]
Pastor P, Roe CM, Villegas A, et al. Apolipoprotein Eepsilon4 modifies Alzheimer’s disease onset in an E280A PS1 kindred. Ann Neurol 2003; 54(2): 163-9.
[http://dx.doi.org/10.1002/ana.10636 ] [PMID: 12891668]
[31]
Wallon D, Rousseau S, Rovelet-Lecrux A, et al. The French series of autosomal dominant early onset Alzheimer’s disease cases: Mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis 2012; 30(4): 847-56.
[http://dx.doi.org/10.3233/JAD-2012-120172 ] [PMID: 22475797]
[32]
Lanoiselée HM, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med; 2017; 14(3)e1002270..
[http://dx.doi.org/10.1371/journal.pmed.1002270] [PMID: 28350801]


open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 3
Year: 2021
Published on: 23 September, 2021
Page: [265 - 272]
Pages: 8
DOI: 10.2174/1567205018666210608120339

Article Metrics

PDF: 111
HTML: 2